These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 25575243)

  • 1. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating.
    Flandreau E; Risbrough V; Lu A; Ableitner M; Geyer MA; Holsboer F; Deussing JM
    Psychoneuroendocrinology; 2015 Mar; 53():16-28. PubMed ID: 25575243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
    Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
    J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice.
    Toth M; Gresack JE; Bangasser DA; Plona Z; Valentino RJ; Flandreau EI; Mansuy IM; Merlo-Pich E; Geyer MA; Risbrough VB
    Neuropsychopharmacology; 2014 May; 39(6):1409-19. PubMed ID: 24326400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predator Stress-Induced CRF Release Causes Enduring Sensitization of Basolateral Amygdala Norepinephrine Systems that Promote PTSD-Like Startle Abnormalities.
    Rajbhandari AK; Baldo BA; Bakshi VP
    J Neurosci; 2015 Oct; 35(42):14270-85. PubMed ID: 26490866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABA(A) and GABA(B) receptor activation.
    Douma TN; Millan MJ; Verdouw PM; Oosting RS; Olivier B; Groenink L
    Neuropharmacology; 2014 Apr; 79():66-74. PubMed ID: 24211652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity.
    Gresack JE; Risbrough VB
    Int J Neuropsychopharmacol; 2011 Oct; 14(9):1179-94. PubMed ID: 21205416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone.
    Dirks A; Groenink L; Schipholt MI; van der Gugten J; Hijzen TH; Geyer MA; Olivier B
    Biol Psychiatry; 2002 Apr; 51(7):583-90. PubMed ID: 11950460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF.
    Groenink L; Dirks A; Verdouw PM; de Graaff M; Peeters BW; Millan MJ; Olivier B
    Biol Psychiatry; 2008 Feb; 63(4):360-8. PubMed ID: 17716630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs.
    Dirks A; Groenink L; Westphal KG; Olivier JD; Verdouw PM; van der Gugten J; Geyer MA; Olivier B
    Neuropsychopharmacology; 2003 Oct; 28(10):1790-8. PubMed ID: 12865891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents.
    Douma TN; Millan MJ; Boulay D; Griebel G; Verdouw PM; Westphal KG; Olivier B; Groenink L
    Psychopharmacology (Berl); 2014 Apr; 231(7):1289-303. PubMed ID: 24186076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues.
    Risbrough VB; Geyer MA; Hauger RL; Coste S; Stenzel-Poore M; Wurst W; Holsboer F
    Neuropsychopharmacology; 2009 May; 34(6):1494-503. PubMed ID: 19020499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.
    Conti LH
    Neuropharmacology; 2012 Jan; 62(1):256-63. PubMed ID: 21835187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats.
    Sutherland JE; Burian LC; Covault J; Conti LH
    Pharmacol Biochem Behav; 2010 Dec; 97(2):227-38. PubMed ID: 20709096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated norepinephrine receptor stimulation in the BNST induces sensorimotor gating deficits via corticotropin releasing factor.
    Rajbhandari AK; Bakshi VP
    Neuropharmacology; 2020 Aug; 172():108090. PubMed ID: 32360378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in corticotropin releasing factor peptide regulation of inhibitory control and excitability in central amygdala corticotropin releasing factor receptor 1-neurons.
    Agoglia AE; Tella J; Herman MA
    Neuropharmacology; 2020 Dec; 180():108296. PubMed ID: 32950560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress.
    Coste SC; Heard AD; Phillips TJ; Stenzel-Poore MP
    Genes Brain Behav; 2006 Mar; 5(2):131-8. PubMed ID: 16507004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits?
    Bakshi VP; Alsene KM; Roseboom PH; Connors EE
    Neuropharmacology; 2012 Feb; 62(2):737-48. PubMed ID: 21288473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior.
    Lu A; Steiner MA; Whittle N; Vogl AM; Walser SM; Ableitner M; Refojo D; Ekker M; Rubenstein JL; Stalla GK; Singewald N; Holsboer F; Wotjak CT; Wurst W; Deussing JM
    Mol Psychiatry; 2008 Nov; 13(11):1028-42. PubMed ID: 18475271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating.
    Vinkers CH; Risbrough VB; Geyer MA; Caldwell S; Low MJ; Hauger RL
    Pharmacol Biochem Behav; 2007 Mar; 86(3):550-8. PubMed ID: 17324452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.